StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
47
This year
4
Publishing Date
2024 - 03 - 07
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 01 - 09
1
2023 - 11 - 27
1
2023 - 10 - 26
1
2023 - 10 - 20
1
2023 - 09 - 25
1
2023 - 09 - 20
1
2023 - 09 - 07
1
2023 - 09 - 04
1
2023 - 08 - 25
2
2023 - 08 - 22
1
2023 - 08 - 21
1
2023 - 08 - 16
1
2023 - 05 - 17
1
2023 - 04 - 13
2
2023 - 03 - 28
1
2023 - 02 - 23
1
2023 - 02 - 15
1
2023 - 01 - 27
1
2022 - 10 - 06
2
2022 - 09 - 21
1
2022 - 09 - 16
1
2022 - 09 - 10
1
2022 - 07 - 13
1
2022 - 07 - 12
1
2022 - 06 - 27
1
2022 - 03 - 01
1
2022 - 01 - 13
1
2021 - 12 - 21
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 11 - 29
1
2021 - 10 - 22
1
2021 - 10 - 04
1
2021 - 08 - 02
1
2021 - 06 - 28
1
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 04 - 28
1
2021 - 04 - 19
1
2021 - 02 - 16
1
2020 - 12 - 22
1
Sector
Distribution services
1
Health services
2
Health technology
47
Manufacturing
4
N/a
1
Tags
Abbvie
1
Agreement
2
America
1
Antibody
1
Application
2
Approval
1
Asia
1
Atopic dermatitis
1
Australia
1
Biotech-bay
1
Biotech-beach
2
Bleeding
1
Bone
2
Breakthrough therapy
1
Cancer
6
Care
1
Cel
1
Cell carcinoma
1
Chmp
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
1
Collaboration
1
Conference
1
Dermatitis
1
Designation
2
Disease
5
Drug
3
Eb613
6
Europe
1
Expansion
2
Expected
3
Fda
5
Fda approval
1
Fda-approvals
2
Food
2
Glioblastoma
2
Global
12
Grant
1
Granted
1
Growing
1
Growth
8
Health
1
Hope
1
Impact
1
Infections
1
International
1
Lung cancer
2
Market
18
Meeting
2
N/a
34
Osteoporosis
7
Phase 2
2
Plague
2
Potential
3
Psoriasis
5
Report
7
Research
7
Therapy
3
Treatment
46
Trial
2
Entities
3m company
21
Abbott laboratories
60
Abbvie inc.
121
Accuray incorporated
21
Adamis pharmaceuticals corporation
19
Adial pharmaceuticals, inc
22
Alnylam pharmaceuticals, inc.
38
Amgen inc.
47
Arcutis biotherapeutics, inc.
25
Arrowhead pharmaceuticals, inc.
21
Astellas pharma inc
51
Astrazeneca plc
52
Bausch health companies inc.
36
Biogen inc.
42
Biohaven pharmaceutical holding company ltd.
19
Bioxcel therapeutics, inc.
20
Boston scientific corporation
21
Brainsway ltd.
41
Bridgebio pharma, inc.
20
Bristol-myers squibb company
94
Cns pharmaceuticals, inc.
26
Coherus biosciences, inc.
28
Compass pathways plc
20
Ecolab inc.
47
Eli lilly and company
180
Fortress biotech, inc.
27
Gilead sciences, inc.
50
Glaxosmithkline plc
103
Hoth therapeutics, inc.
24
Incyte corporation
77
Intellia therapeutics, inc.
32
Jazz pharmaceuticals plc
20
Johnson & johnson
208
Karyopharm therapeutics inc.
33
Koninklijke philips n.v.
21
Medicinova, inc.
24
Medtronic plc
46
Merck & company, inc.
65
Moleculin biotech, inc.
28
Novartis ag
144
Novo nordisk a/s
37
Nrx pharmaceuticals inc
20
Orange
87
Perrigo company
21
Pfizer, inc.
74
Reata pharmaceuticals, inc.
28
Regeneron pharmaceuticals, inc.
57
Regenxbio inc.
25
Sanofi
293
Sorrento therapeutics, inc.
37
Takeda pharmaceutical company limited
53
Teleflex incorporated
21
Teva pharmaceutical industries ltd
79
Tg therapeutics, inc.
24
Tonix pharmaceuticals holding corp.
32
Ultragenyx pharmaceutical inc.
25
Verrica pharmaceuticals inc.
23
Vertex pharmaceuticals incorporated
27
Viatris inc.
46
Xylem inc.
35
Symbols
ABBV
8
ABCM
1
ABCZF
1
ABT
5
ADAP
1
ALPMF
3
ALPMY
3
AMGN
47
APTX
1
AZN
7
AZNCF
7
BAX
1
BEIGF
1
BGNE
5
BHC
1
BIIB
2
BLRX
1
BMY
9
CCXI
1
CRNX
1
DFFN
1
ENTX
6
FUSN
1
GLAXF
6
GMAB
1
GNMSF
1
GSK
6
HOTH
1
JNJ
4
KIDS
1
KPTI
1
LGND
1
LGVN
1
LLY
8
MCK
1
MREO
1
NNOX
1
NVO
2
NVS
14
NVSEF
14
ONCS
1
PFE
1
QDEL
1
RARE
1
SNY
10
SNYNF
10
TAK
2
TECH
1
TEVJF
10
TMO
1
UCBJF
1
UCBJY
1
VRTX
1
VTRS
6
Exchanges
Nasdaq
47
Nyse
31
Crawled Date
2024 - 03 - 07
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 01 - 09
1
2023 - 11 - 27
1
2023 - 10 - 26
1
2023 - 10 - 20
1
2023 - 09 - 25
1
2023 - 09 - 20
1
2023 - 09 - 08
1
2023 - 09 - 04
1
2023 - 08 - 25
2
2023 - 08 - 22
1
2023 - 08 - 21
1
2023 - 08 - 16
1
2023 - 05 - 17
1
2023 - 04 - 13
2
2023 - 03 - 28
1
2023 - 02 - 23
1
2023 - 02 - 15
1
2023 - 01 - 27
1
2022 - 10 - 06
2
2022 - 09 - 21
1
2022 - 09 - 16
1
2022 - 09 - 10
1
2022 - 07 - 13
1
2022 - 07 - 12
1
2022 - 06 - 27
1
2022 - 03 - 01
1
2022 - 01 - 13
1
2021 - 12 - 21
1
2021 - 12 - 14
2
2021 - 11 - 29
1
2021 - 10 - 22
1
2021 - 10 - 04
1
2021 - 08 - 02
1
2021 - 06 - 28
1
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 04 - 28
1
2021 - 04 - 19
1
2021 - 02 - 17
1
2020 - 12 - 23
1
Crawled Time
00:00
5
01:00
3
02:00
1
03:00
2
08:20
1
09:00
1
10:00
3
12:00
2
12:30
2
13:00
4
13:15
1
14:00
1
14:30
1
15:20
2
15:30
2
16:00
2
17:00
1
18:00
2
19:00
1
20:00
3
21:00
2
22:00
3
23:00
2
Source
www.biospace.com
13
www.globenewswire.com
3
www.prnewswire.com
31
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
entities :
Amgen inc.
save search
Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-8.86%
|
O:
1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-2.59%
|
O:
1.62%
H:
0.0%
C:
0.0%
QDEL
|
News
M
|
$38.28
-1.11%
-1.12%
1M
|
Health Technology
|
-9.7%
|
O:
1.14%
H:
4.36%
C:
3.16%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-3.49%
|
O:
-0.1%
H:
0.18%
C:
-1.25%
cancer
treatment
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
9.56%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-4.32%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
1.05%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$393.51
0.1%
0.1%
950K
|
Health Technology
|
-5.51%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.13%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-13.9%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
11.85%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-8.11%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
9.56%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-7.87%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
1.43%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-3.11%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-6.33%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-3.85%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.05%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
9.65%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-8.31%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
43.47%
2.2K
|
Health Technology
|
-22.38%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-11.87%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.46
-1.11%
500K
|
Manufacturing
|
-23.94%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-13.07%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-10.52%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-14.14%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published:
2023-11-27
(Crawled : 23:00)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
11.65%
|
O:
-0.5%
H:
0.0%
C:
0.0%
KPTI
|
$1.265
-8.33%
-9.09%
1.3M
|
Health Technology
|
95.05%
|
O:
4.0%
H:
1.93%
C:
-7.72%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
1.01%
|
O:
0.03%
H:
0.85%
C:
0.44%
report
hope
treatment
research
global
virus
therapy
market
A large international study of migraine reveals new biological pathways for treatment
Published:
2023-10-26
(Crawled : 18:00)
- biospace.com/
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-1.92%
|
O:
-0.24%
H:
0.71%
C:
-0.66%
international
treatment
migraine
study
Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published:
2023-10-20
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.594
43.47%
2.2K
|
Health Technology
|
-26.37%
|
O:
-4.45%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-14.38%
|
O:
-3.95%
H:
0.0%
C:
-0.72%
ALPMY
|
News
|
$9.46
-1.11%
500K
|
Manufacturing
|
-25.1%
|
O:
-2.89%
H:
3.67%
C:
2.85%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
11.9%
|
O:
0.42%
H:
0.54%
C:
0.11%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.07%
|
O:
-0.17%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-4.87%
|
O:
0.0%
H:
0.16%
C:
-0.64%
report
treatment
global
trends
leukemia
market
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published:
2023-09-25
(Crawled : 03:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.89%
|
O:
-0.81%
H:
1.63%
C:
-1.03%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
12.99%
|
O:
3.72%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
15.15%
|
O:
-0.21%
H:
1.14%
C:
1.04%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-7.97%
|
O:
-0.31%
H:
0.98%
C:
0.97%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
5.8%
|
O:
-0.13%
H:
0.91%
C:
0.88%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
7.14%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
9.15%
|
O:
-1.17%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-0.29%
|
O:
-0.06%
H:
0.1%
C:
-0.25%
abbvie
treatment
thyroid
market
Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published:
2023-09-20
(Crawled : 22:00)
- prnewswire.com
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
41.78%
|
O:
-0.79%
H:
0.0%
C:
-1.26%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-10.14%
|
O:
-0.7%
H:
0.06%
C:
-0.75%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
30.85%
|
O:
-1.47%
H:
0.0%
C:
0.0%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
6.62%
|
O:
-0.04%
H:
0.76%
C:
-0.16%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-16.78%
|
O:
-1.16%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-1.67%
|
O:
0.22%
H:
0.15%
C:
-0.98%
psoriasis
treatment
novartis
Advancements in Atherosclerosis Treatments Fuel Expansion of the Global Market to 2032
Published:
2023-09-07
(Crawled : 00:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
11.0%
|
O:
0.0%
H:
2.1%
C:
1.1%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.84%
|
O:
-0.29%
H:
0.38%
C:
-0.22%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-9.54%
|
O:
-0.34%
H:
0.0%
C:
0.0%
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
3.8%
|
O:
0.0%
H:
3.09%
C:
2.61%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-13.37%
|
O:
0.46%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
4.93%
|
O:
0.53%
H:
1.79%
C:
1.44%
expansion
global
market
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published:
2023-09-04
(Crawled : 16:00)
- prnewswire.com
MREO
|
$2.66
3.1%
3.01%
810K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
KIDS
|
$29.485
-1.39%
-1.41%
81K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
RARE
|
$43.38
-1.65%
-1.68%
770K
|
Health Technology
|
Email alert
Add to watchlist
treatment
research
global
collaboration
growth
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published:
2023-08-25
(Crawled : 14:30)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-0.51%
|
O:
-3.27%
H:
3.65%
C:
3.36%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
0.55%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
4.02%
|
O:
0.19%
H:
0.25%
C:
-0.28%
disease
report
cancer
treatment
research
global
technology
Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023
Published:
2023-08-25
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-0.51%
|
O:
-3.27%
H:
3.65%
C:
3.36%
ALPMY
|
News
|
$9.46
-1.11%
500K
|
Manufacturing
|
-37.61%
|
O:
-4.14%
H:
5.37%
C:
4.39%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-7.7%
|
O:
0.67%
H:
0.37%
C:
0.26%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.73%
|
O:
0.51%
H:
0.0%
C:
0.0%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
11.38%
|
O:
-0.11%
H:
0.44%
C:
-0.22%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
2.78%
|
O:
-0.73%
H:
0.0%
C:
0.0%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
0.55%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
4.02%
|
O:
0.19%
H:
0.25%
C:
-0.28%
treatment
global
market
Global Postmenopausal Osteoporosis Treatment Market 2023-2030: Asia-Pacific Showing Strong Growth Potential
Published:
2023-08-22
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.27%
|
O:
0.56%
H:
0.1%
C:
-0.32%
LLY
|
News
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
35.6%
|
O:
0.55%
H:
0.12%
C:
-0.6%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
3.62%
|
O:
0.73%
H:
0.13%
C:
-0.82%
osteoporosis
treatment
global
potential
growth
market
AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING
Published:
2023-08-21
(Crawled : 20:00)
- prnewswire.com
BGNE
S
|
$131.94
0.06%
0.06%
130K
|
Health Technology
|
-31.65%
|
O:
-0.27%
H:
0.99%
C:
-0.67%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
2.39%
|
O:
-0.18%
H:
0.06%
C:
-1.01%
lumakras
fda
treatment
meeting
application
Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-0.54%
|
O:
-0.99%
H:
1.45%
C:
1.36%
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
8.11%
|
O:
0.56%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
2.25%
|
O:
2.02%
H:
0.72%
C:
-0.49%
treatment
global
market
Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published:
2023-05-17
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-10.51%
|
O:
-1.32%
H:
0.92%
C:
-1.34%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.46%
|
O:
-0.51%
H:
0.0%
C:
-1.05%
FUSN
|
$21.24
0.0%
330K
|
Health Technology
|
365.79%
|
O:
-1.54%
H:
1.34%
C:
-2.67%
DFFN
4
|
$6.6
11.68%
-34.32%
350K
|
Health Technology
|
14.59%
|
O:
-0.25%
H:
0.0%
C:
-0.78%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-9.32%
|
O:
0.07%
H:
0.03%
C:
-0.84%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
17.14%
|
O:
-0.82%
H:
0.03%
C:
-0.44%
propel
report
expected
treatment
global
growth
glioblastoma
market
Seborrheic keratosis treatment market size to grow by USD 786.38 million between 2021 and 2026; Aclaris Therapeutics Inc., BioLineRx Ltd., among others, identified as key vendors - Technavio
Published:
2023-04-13
(Crawled : 10:00)
- prnewswire.com
ABBV
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
0.96%
|
O:
-0.84%
H:
1.16%
C:
1.05%
BLRX
|
News
|
$0.6411
3.17%
3.07%
310K
|
Health Technology
|
-40.93%
|
O:
-0.93%
H:
3.76%
C:
0.94%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
6.99%
|
O:
-0.36%
H:
1.33%
C:
1.14%
treatment
therapeutics
market
The Glioblastoma Multiforme (GBM) Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players
Published:
2023-04-13
(Crawled : 10:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
-8.11%
|
O:
0.0%
H:
1.63%
C:
1.63%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
16.68%
|
O:
1.25%
H:
0.51%
C:
0.51%
NVS
|
News
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-3.51%
|
O:
1.3%
H:
0.56%
C:
0.51%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
-7.45%
|
O:
0.39%
H:
1.05%
C:
0.97%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
6.99%
|
O:
-0.36%
H:
1.33%
C:
1.14%
expected
treatment
growth
glioblastoma
market
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published:
2023-03-28
(Crawled : 13:00)
- biospace.com/
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.1%
|
O:
0.01%
H:
0.75%
C:
0.18%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
12.74%
|
O:
0.1%
H:
0.71%
C:
0.62%
approval
psoriasis
treatment
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.